Long-term results of radiochemotherapy for solitary lymph node metastasis after curative resection of esophageal cancer

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 1, 2012, Pages 172-177

  Jingu, Keiichi ^a   Ariga, Hisanori ^a   Nemoto, Kenji ^b   Narazaki, Kakutaro ^a   Umezawa, Rei ^a   Takeda, Ken ^a   Koto, Masashi ^a   Sugawara, Toshiyuki ^a   Kubozono, Masaki ^a   Miyata, Go ^a   Onodera, Ko ^a   Yamada, Shogo ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

Long term results; Postoperative recurrent esophageal cancer; Prognostic factor; Radiochemotherapy; Solitary lymph node metastasis

Indexed keywords

ESOPHAGEAL CANCER; LONG-TERM RESULTS; LYMPH NODE METASTASIS; PROGNOSTIC FACTORS; RADIOCHEMOTHERAPY;

CHEMORADIOTHERAPY; CHEMOTHERAPY; DIAGNOSIS; DISEASES; ENZYME INHIBITION; PATHOLOGY; PLATINUM;

BODY FLUIDS;

CISPLATIN; DOCETAXEL; FLUOROURACIL; NEDAPLATIN;

ARTICLE; CANCER PROGNOSIS; CAUSE SPECIFIC SURVIVAL; CHEMORADIOTHERAPY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; HUMAN; LONG TERM CARE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; TREATMENT RESPONSE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HUMANS; JAPAN; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGANOPLATINUM COMPOUNDS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL ANALYSIS; TAXOIDS;

EID: 84859879156     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.06.1978     Document Type: Article

References (27)

1. Herbella FA, Patti MG. Esophageal cancer: eMedicine: oncology, 2011-09-02. Available at: http://emedicine.medscape.com/article/277930- overview#a0199.
2. S. Besharat, A. Jabbari, and S. Semnani Inoperable esophageal cancer and outcome of palliative care World J Gastroenterol 14 2008 3725 3728
3. S. Nakagawa, T. Kanda, and S. Kosugi Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy J Am Coll Surg 198 2004 205 211
4. C. Mariette, J.M. Bolon, and G. Piessen Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease Cancer 97 2003 1616 1623
5. M.S. Bhansali, H. Fujita, and T. Kakegawa Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus World J Surg 21 1997 275 281
6. H. Kato, T. Miyazaki, and M. Nakajima Prediction of hematogenous recurrence in patients with esophageal carcinoma Jpn J Thorac Cardiovasc Surg 51 2003 599 608
7. J.B. Hulscher, J.W. van Sandick, and J.G. Tijssen The recurrence pattern of esophageal carcinoma after transhiatal resection J Am Coll Surg 191 2000 143 148
8. I.D. Kyriazanos, M. Tachibana, and M. Shibakita Pattern of recurrence after extended esophagectomy for squamous cell carcinoma of the esophagus Hepatogastroenterology 50 2003 115 120
9. S. Natsugoe, M. Matsumoto, and H. Okumura Clinical course and outcome after esophagectomy with three-field lymphadenectomy in esophageal cancer Langenbecks Arch Surg 395 2010 341 346
10. K. Maruyama, S. Motoyama, and A. Anbai Therapeutic strategy for the treatment of postoperative recurrence of esophageal squamous cell carcinoma: Clinical efficacy of radiotherapy Dis Esophagus 24 2011 166 171
11. T. Nakamura, M. Ota, and K. Narumiya Multimodal treatment for lymph node recurrence of esophageal carcinoma after curative resection Ann Surg Oncol 15 2008 2451 2547
12. M. Yano, K. Takachi, and Y. Doki Prognosis of patients who develop cervical lymph node recurrence following curative resection for thoracic esophageal cancer Dis Esophagus 19 2006 73 77
13. H. Shimada, H. Kitabayashi, and Y. Nabeya Treatment response and prognosis of patients after recurrence of esophageal cancer Surgery 133 2003 24 31
14. Y. Nishimura, R. Koike, and K. Nakamatsu Concurrent chemoradiotherapy with protracted infusion of 5-FU and cisplatin for postoperative recurrent or residual esophageal cancer Jpn J Clin Oncol 33 2003 341 345
15. J.L. Raoul, E. Le Prise, and B. Meunier Combined radiochemotherapy for postoperative recurrence of oesophageal cancer Gut 37 1995 174 176
16. K. Nemoto, H. Ariga, and Y. Kakuto Radiation therapy for loco-regionally recurrent esophageal cancer after surgery Radiother Oncol 61 2001 165 168
17. H. Yamashita, K. Nakagawa, and M. Tago Salvage radiotherapy for postoperative loco-regional recurrence of esophageal cancer Dis Esophagus 18 2005 215 220
18. J.C. Lu, C. Kong, and H. Tao Radiotherapy with or without concurrent chemotherapy for lymph node recurrence after radical surgery of thoracic esophageal squamous cell carcinoma Int J Radiat Oncol Biol Phys 78 2010 710 714
19. K. Jingu, K. Nemoto, and H. Matsushita Long-term results of the phase II study on radiotherapy combined with nedaplatin and 5-FU for postoperative locoregional recurrent esophageal cancer Eur J Cancer suppl 5 2007 273
20. H. Kato, M. Fukuchi, and T. Miyazaki Classification of recurrent esophageal cancer after radical esophagectomy with two- or three-field lymphadenectomy Anticancer Res 25 2005 3461 3467
21. B.D. Minsky, T.F. Pajak, and R.J. Ginsberg INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy J Clin Oncol 20 2002 1167 1174
22. M. Kenjo, T. Uno, and Y. Murakami Radiation therapy for esophageal cancer in Japan: Results of the Patterns of Care Study 1999-2001 Int J Radiat Oncol Biol Phys 75 2009 357 363
23. H.L. Jin, H. Zhu, and T.S. Ling Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta-analysis World J Gastroenterol 15 2009 5983 5991
24. K. Muro, N. Ando, and T. Nishimaki A phase IIstudy of nedaplatin and 5-fluorouracil in metastatic squamous cell carcinoma of the esophagus: Japan Clinical Oncology Group study (JCOG 9905) Proc ASCO 22 2003 277
25. S.G. Urba, K. Chansky, and P.J. Van Veldhuizen Gemcitabine and cisplatin for patients with metastatic or recurrent esophageal carcinoma: A Southwest Oncolgy Group study Invest New Drugs 22 2004 91 97
26. C.H. Hsu, A.L. Cheng, and C. Hsu A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil Anticancer Res 22 2002 3621 3627
27. T. Tanaka, H. Fujita, and S. Sueyoshi Second-line combination chemotherapy with docetaxel for cisplatin-pretreated refractory metastatic esophageal cancer: A preliminary report of initial experience Chemotherapy 53 2007 449 453